Prescription Drug Transparency and Affordability Act

# Prescription Drug Transparency and Affordability Act Summary **What the Bill Would Do:** The Prescription Drug Transparency and Affordability Act (HR 2450) aims to make prescription drug prices more affordable and transparent for American consumers. While specific details about the bill's provisions are limited in the available information, bills with this title typically focus on requiring drug manufacturers to disclose pricing information and implementing measures to reduce out-of-pocket costs for patients purchasing medications. **Who It Affects:** This legislation would primarily impact patients who purchase prescription drugs, insurance companies, and pharmaceutical manufacturers. Seniors on Medicare and lower-income Americans who struggle with medication costs would likely be among those most affected by any affordability measures included in the final bill. **Current Status:** The bill is currently in committee review, meaning it has been introduced but has not yet advanced to a full vote in the House of Representatives.

As a relatively new bill in the 119th Congress, it remains in the early stages of the legislative process. *Note: The summary above is based on limited available information. For comprehensive details about specific provisions, readers are encouraged to review the full bill text on Congress.gov.*.